Recent Advances in Lipid Nanoparticle-Mediated Respiratory and Gastrointestinal Mucosal Delivery of Nucleic Acids
Bioengineering · 31.07.2026 · 13 (8) · 884
DOI: 10.3390/bioengineering13080884 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 31.07.2026. Verfasst von Zefan Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: First People's Hospital of Shuangliu District (West China Airport Hospital of Sichuan University), Chengdu 610093, China. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Sichuan Province, West China Hospital of Sichuan University.
Abstract (Originalsprache)
The clinical translation of nucleic acids is severely hindered by multiple delivery barriers, such as enzymatic degradation, poor cellular uptake, endosomal entrapment, and rapid systemic clearance. Despite the remarkable therapeutic potential of these agents, conventional delivery systems often fail to address these challenges. Lipid nanoparticles (LNPs) have emerged as a versatile platform to overcome these obstacles, offering tunable physicochemical properties, high encapsulation efficiency, and pH-responsive endosomal escape. This review summarizes recent advances in LNP-based respiratory and gastrointestinal mucosal delivery of nucleic acids, with emphasis on formulation strategies for overcoming mucus and epithelial barriers. To overcome mucosal barriers, LNP studies have shown that keeping particle size below the local mucus mesh size (~100 nm), tuning surface charge toward near-neutrality via pH-responsive ionizable lipids, and maintaining a neutral, deformable, moderately PEGylated surface during the mucin transport stage can increase transmucosal diffusivity several-fold over conventional cationic LNPs. We further discuss current limitations and propose future directions, emphasizing the need for the integration of the pathological and physiological characteristics of specific mucosa with artificial intelligence (AI) platforms to develop intelligent and personalized delivery platforms with “spatiotemporal adaptive” capabilities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First People's Hospital of Shuangliu District (West China Airport Hospital of Sichuan University), Chengdu 610093, China.
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug, West China School of Pharmacy, Sichuan University, Chengdu…
- Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China.
- Sichuan Higher Education Institute Key Laboratory of Structure-Specific Small Molecule Drugs, Institute of Materia Medica, School of Pharmacy, Chengdu Medical College, Chengdu 610500, China.
ORCID-Profile: Yucheng Xiang
Förderung
- National Natural Science Foundation of China
- Science and Technology Department of Sichuan Province
- West China Hospital of Sichuan University
- Sichuan Medical Association
- National Key R&D Program of China
- “Qimingxing” Research Fund for Young Talents
Zitieren
APA
Liu, Z., Fu, J., Mo, N., Yang, J., Yan, S., Hu, J., Zhou, M., Li, L., & Xiang, Y. (2026). Recent Advances in Lipid Nanoparticle-Mediated Respiratory and Gastrointestinal Mucosal Delivery of Nucleic Acids. Bioengineering, 13(8), 884. https://doi.org/10.3390/bioengineering13080884
Vancouver
Liu Z, Fu J, Mo N, Yang J, Yan S, Hu J, et al. Recent Advances in Lipid Nanoparticle-Mediated Respiratory and Gastrointestinal Mucosal Delivery of Nucleic Acids. Bioengineering. 2026;13(8):884. doi:10.3390/bioengineering13080884
BibTeX
@article{Liu2026,
author = {Liu, Zefan and Fu, Jiaqi and Mo, Nan and Yang, Juan and Yan, Shenao and Hu, Jing and Zhou, Minglu and Li, Lian and Xiang, Yucheng},
title = {Recent Advances in Lipid Nanoparticle-Mediated Respiratory and Gastrointestinal Mucosal Delivery of Nucleic Acids},
journal = {Bioengineering},
year = {2026},
volume = {13},
number = {8},
pages = {884},
doi = {10.3390/bioengineering13080884}
}
EUVIMED